HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andi R Masters Selected Research

abemaciclib

1/2023Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andi R Masters Research Topics

Disease

2Neoplasms (Cancer)
01/2023 - 01/2018
1Nerve Sheath Neoplasms (Nerve Sheath Neoplasm)
01/2023
1Amyloid Plaque
01/2022
1Alzheimer Disease (Alzheimer's Disease)
01/2022
1Neurilemmoma (Schwannoma)
01/2018
1Sensorineural Hearing Loss
01/2018
1Neurofibromatosis 2 (Neurofibromatosis Type II)
01/2018

Drug/Important Bio-Agent (IBA)

1abemaciclibIBA
01/2023
1LY3214996IBA
01/2023
1verubecestatIBA
01/2022
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2018
1Celecoxib (Celebrex)FDA Link
01/2018

Therapy/Procedure

1Therapeutics
01/2023